Literature DB >> 15368430

Telomeres and telomerase: a dual role in hepatocarcinogenesis.

Ande Satyanarayana1, Michael P Manns, K Lenhard Rudolph.   

Abstract

Telomere shortening limits the proliferative capacity of primary human cells and restrains the regenerative capacity of organ systems during chronic diseases and aging. Telomere shortening apparently has a dual role in tumor development and progression. On the one hand, it induces chromosomal instability and the initiation of cancer; on the other hand, tumor progression requires stabilization of telomeres. The predominant mechanism of telomere stabilization in tumor cells is the activation of the telomere-synthesizing enzyme telomerase. The potential use of telomerase activators for the treatment of regenerative disorders will ultimately depend on their effects on tumorigenesis. This review focuses on the role of telomere shortening and telomerase in carcinogenesis with a special focus on hepatocellular carcinoma. Copyright 2004 American Association for the Study of Liver Diseases

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368430     DOI: 10.1002/hep.20308

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  35 in total

1.  The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.

Authors:  André Lechel; Ande Satyanarayana; Zhenyu Ju; Ruben R Plentz; Sonja Schaetzlein; Cornelia Rudolph; Ludwig Wilkens; Stephanie U Wiemann; Gabriele Saretzki; Nisar P Malek; Michael P Manns; Jan Buer; K Lenhard Rudolph
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

Review 2.  Hepatocellular carcinoma: therapy and prevention.

Authors:  Hubert E Blum
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 3.  Stem cell function and maintenance - ends that matter: role of telomeres and telomerase.

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

Review 4.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

5.  Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.

Authors:  Shaogui Wan; Hie-Won Hann; Zhong Ye; Richard S Hann; Yinzhi Lai; Chun Wang; Ling Li; Ronald E Myers; Bingshan Li; Jinliang Xing; Hushan Yang
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

6.  Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.

Authors:  Xiaoying Fu; Shaogui Wan; Hie-Won Hann; Ronald E Myers; Richard S Hann; Jennifer Au; Bicui Chen; Jinliang Xing; Hushan Yang
Journal:  Eur J Cancer       Date:  2012-03-21       Impact factor: 9.162

Review 7.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

8.  Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.

Authors:  Yvonne Begus-Nahrmann; Daniel Hartmann; Johann Kraus; Parisa Eshraghi; Annika Scheffold; Melanie Grieb; Volker Rasche; Peter Schirmacher; Han-Wong Lee; Hans A Kestler; André Lechel; K Lenhard Rudolph
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

9.  Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.

Authors:  Deng-Fu Yao; Wei Wu; Min Yao; Li-Wei Qiu; Xin-Hua Wu; Xiao-Qin Su; Li Zou; Deng-Bing Yao; Xian-Yong Meng
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

10.  Evolving therapies in the treatment of hepatocellular carcinoma.

Authors:  Hans Christian Spangenberg; Robert Thimme; Hubert E Blum
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.